Clinical Trials Browser

OTHER × Neurotoxicity Syndromes × Tadalafil × Clear all

NCT07333976 2026-01-12

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Phase 2 Completed

Peripheral Nervous System Diseases, Neurotoxicity Syndromes